Fernando José Magro Dias


AuthID: R-000-50A

Confirmed Publications: 275



61
TITLE: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease  Full Text
AUTHORS: Pedro Pinto-Lopes; Joana Afonso ; Rui Pinto-Lopes; Cátia Rocha; Paula Lago; Raquel Gonçalves; Helena Tavares De Sousa; Guilherme Macedo ; Cláudia Camila Dias ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: Inflammatory Bowel Diseases, VOLUME: 26, ISSUE: 11
INDEXED IN: CrossRef: 12
IN MY: ORCID
62
TITLE: The daily impact of COVID-19 in gastroenterology
AUTHORS: Magro, F ; Abreu, C ; Rahier, JF;
PUBLISHED: 2020, SOURCE: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, VOLUME: 8, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 33
63
TITLE: The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
AUTHORS: Maria Manuela Estevinho; Fernando Magro ;
PUBLISHED: 2020, SOURCE: GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, VOLUME: 27, ISSUE: 4
INDEXED IN: Scopus WOS
64
TITLE: Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis
AUTHORS: Paula Sousa; Maria Manuela Estevinho; Claudia Camila Dias ; Paula Ministro; Uri Kopylov; Silvio Danese; Laurent Peyrin Biroulet; Fernando Magro ;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 7
INDEXED IN: WOS CrossRef: 14
65
TITLE: Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties  Full Text
AUTHORS: Helena Tavares de Sousa; Maria Manuela Estevinho; Laurent Peyrin Biroulet; Silvio Danese; Claudia Camila Dias ; Fatima Carneiro ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
66
TITLE: Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease  Full Text
AUTHORS: Ferreira Duarte, M; Estevinho, MM; Duarte Araujo, M ; Magro, F ; Morato, M ;
PUBLISHED: 2020, SOURCE: INFLAMMATORY BOWEL DISEASES, VOLUME: 26, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 12
67
TITLE: Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis  Full Text
AUTHORS: Severine Vermeire; Milan Lukas; Fernando Magro ; Shashi Adsul; Dirk Lindner; Maria Rosario; Jeannine Roth; Silvio Danese;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 8
INDEXED IN: WOS CrossRef: 13
IN MY: ORCID
68
TITLE: Accuracy of the new rapid test for monitoring adalimumab levels
AUTHORS: Catia Rocha; Joana Afonso ; Paula Lago; Bruno Arroja; Ana I Vieira; Claudia C Dias ; Fernando Magro ;
PUBLISHED: 2019, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 12
INDEXED IN: WOS CrossRef: 12
69
TITLE: Anti-TNF treatment failure: drug levels, immunogenicity, or both?
AUTHORS: Fernando Magro ;
PUBLISHED: 2019, SOURCE: LANCET GASTROENTEROLOGY & HEPATOLOGY, VOLUME: 4, ISSUE: 5
INDEXED IN: Scopus WOS
70
TITLE: Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One?
AUTHORS: Fernando Magro ; Rosa Coelho; Armando Peixoto;
PUBLISHED: 2019, SOURCE: CURRENT MEDICINAL CHEMISTRY, VOLUME: 26, ISSUE: 2
INDEXED IN: Scopus WOS
Page 7 of 28. Total results: 275.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service